Jia C - Search Results

1

HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.

Jia C, Guo Y, Chen Y, Wang X, Xu Q, Zhang Y, Quan L. Jia C, et al. J Transl Med. 2022 Nov 18;20(1):537. doi: 10.1186/s12967-022-03750-8. J Transl Med. 2022. PMID: 36401285 Free PMC article.

2

Abnormal vascular endothelial growth factor protein expression may be correlated with poor prognosis in diffuse large B-cell lymphoma: A meta-analysis.

Jiang L, Sun JH, Quan LN, Tian YY, Jia CM, Liu ZQ, Liu AC. Jiang L, et al. J Cancer Res Ther. 2016 Apr-Jun;12(2):605-11. doi: 10.4103/0973-1482.146086. J Cancer Res Ther. 2016. PMID: 27461618 Free article.

3

miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1.

Jia CM, Tian YY, Quan LN, Jiang L, Liu AC. Jia CM, et al. Pathol Res Pract. 2018 Sep;214(9):1388-1394. doi: 10.1016/j.prp.2018.07.025. Epub 2018 Jul 27. Pathol Res Pract. 2018. PMID: 30098829

4

Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo.

Jia C, Kong D, Guo Y, Li L, Quan L. Jia C, et al. Biochem Biophys Res Commun. 2018 Nov 2;505(3):720-725. doi: 10.1016/j.bbrc.2018.09.140. Epub 2018 Oct 3. Biochem Biophys Res Commun. 2018. PMID: 30292410

5

Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma.

Yan S, Jia C, Quan L, Zhao L, Tian Y, Liu A. Yan S, et al. Among authors: jia c. Mol Med Rep. 2019 Sep;20(3):2459-2467. doi: 10.3892/mmr.2019.10448. Epub 2019 Jul 1. Mol Med Rep. 2019. PMID: 31322189

6

Proteomics-Based Approach Reveals the Involvement of SERPINB9 in Recurrent and Relapsed Multiple Myeloma.

Chen Y, Quan L, Jia C, Guo Y, Wang X, Zhang Y, Jin Y, Liu A. Chen Y, et al. Among authors: jia c. J Proteome Res. 2021 May 7;20(5):2673-2686. doi: 10.1021/acs.jproteome.1c00007. Epub 2021 Mar 2. J Proteome Res. 2021. PMID: 33650432

7

Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.

Jia C, Guo Y, Chen Y, Wang X, Xu Q, Zhang Y, Quan L. Jia C, et al. J Transl Med. 2023 Jan 30;21(1):58. doi: 10.1186/s12967-023-03904-2. J Transl Med. 2023. PMID: 36717915 Free PMC article. No abstract available.

8

Prognostic marker CD27 and its micro-environmental in multiple myeloma.

Wang X, Luo K, Xu Q, Chi L, Guo Y, Jia C, Quan L. Wang X, et al. Among authors: jia c. BMC Cancer. 2024 Mar 19;24(1):352. doi: 10.1186/s12885-024-11945-z. BMC Cancer. 2024. PMID: 38504180 Free PMC article.

9

The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients.

Chen C, Dong Q, Wang H, Dong S, Wang S, Lin W, Jia C, Dong M, Jin Y, Liu D. Chen C, et al. Among authors: jia c. Ann Hematol. 2025 Jan 8. doi: 10.1007/s00277-024-06144-6. Online ahead of print. Ann Hematol. 2025. PMID: 39774928

10

[Clinical and molecular-biological study of a May-Hegglin anomaly family].

Shao XR, Li JZ, Ma J, Zhan ZM, Liang H, She XN, Lu HL, Wang LC, Jia CM, Wu LJ, Jin MH, Chen LJ. Shao XR, et al. Zhonghua Xue Ye Xue Za Zhi. 2004 Sep;25(9):548-51. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15569536 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,037 results

Search Page

Filters